Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.
Kim Y, Saini U, Kim D, Hernandez-Aguirre I, Hedberg J, Martin A, Mo X, Cripe TP, Markert J, Cassady KA, Dhital R.
Kim Y, et al.
Front Immunol. 2024 Jun 4;15:1375413. doi: 10.3389/fimmu.2024.1375413. eCollection 2024.
Front Immunol. 2024.
PMID: 38895115
Free PMC article.